Evidence map›Paper›PMID 27643752›Full record

ArticleBlood transfusion = Trasfusione del sangue2018

Leucocyte cytokines dominate platelet cytokines overtime in non-leucoreduced platelet components.

Chaker Aloui, Tahar Chakroun, Antoine Prigent, Saloua Jemni-Yacoub, Fabrice Cognasse, Sandrine Laradi, Olivier Garraud

Open access · greenAbstract read
In one paragraph

Article in Blood transfusion = Trasfusione del sangue, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Chaker AlouiGIMAP-EA3064, University of Lyon, Saint-Etienne, France.
Tahar ChakrounRegional Blood Transfusion Centre, CHU Farhat Hached, Sousse, Tunisia.
Antoine PrigentGIMAP-EA3064, University of Lyon, Saint-Etienne, France.
Saloua Jemni-YacoubRegional Blood Transfusion Centre, CHU Farhat Hached, Sousse, Tunisia.
Fabrice CognasseGIMAP-EA3064, University of Lyon, Saint-Etienne, France.
Sandrine LaradiGIMAP-EA3064, University of Lyon, Saint-Etienne, France.
Olivier GarraudGIMAP-EA3064, University of Lyon, Saint-Etienne, France.
Université Claude Bernard Lyon 1 · FRHôpital Farhat Hached · TN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLeucoreduction of blood components, including platelet components, is strongly encouraged but not yet universal, especially outside high income countries. As both leucocytes and platelets secrete copious amounts of pro-inflammatory cytokines/chemokines under various conditions and during storage, we investigated the potential of the respective secretory programmes of these cells in order to evaluate their subsequent pathophysiological effects. MATERIAL AND

methodsA total of 158 individual non-leucoreduced platelet components were obtained from Tunisian donors and tested for characteristic biological response modifiers (BRM) of leukocytes (IL-1β, IL-8), platelets (sCD62P, sCD40L) and both cell types (TNF-α, RANTES) in the presence or absence of thrombin stimulation and after different periods of storage (up to 5 days). BRM levels were determined using enzyme-linked immunosorbent assays and Luminex technology. Platelet-leucocyte aggregate formation during storage was analysed using flow cytometry.

resultsLeucocyte- and platelet-associated BRM had clearly distinct profiles both at the onset (day 0) and termination (day 5) of the observation period but altered during the intermediate period so that their respective importance was inverted; in fact, the profiles were merged and indistinguishable on days 2-3. The leucocyte-derived BRM largely dominated over platelet-derived ones and further altered the BRM platelet secretion programme. DISCUSSION: This study contributes substantial, new information on leucocyte/platelet interactions and their likely role in transfusion when leucodepletion cannot be performed or is only partially achieved.

Indexed as

Blood PreservationBlood PlateletsCytokinesFemaleHumansLeukocytesMaleTime FactorsCytokines

Identifiers

PMID27643752
PMCPMC5770316
OpenAlexW2523658466

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.